| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -225,605 | -100.0% | -0.15% | – |
| AMAM | Exit | AMBRX BIOPHARMA INCcall | $0 | – | -209,600 | -100.0% | -0.16% | – |
| ETNB | Exit | 89BIO INCcall | $0 | – | -329,100 | -100.0% | -0.34% | – |
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -1,358,709 | -100.0% | -0.68% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -1,212,828 | -100.0% | -0.75% | – |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -1,081,767 | -100.0% | -0.86% | – | |
| VOR | Exit | VOR BIOPHARMA INC | $0 | – | -6,461,467 | -100.0% | -0.93% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -2,944,513 | -100.0% | -0.96% | – | |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -926,432 | -100.0% | -1.02% | – |
| IMTX | Exit | IMMATICS N.V | $0 | – | -2,058,447 | -100.0% | -1.62% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -2,421,743 | -100.0% | -1.88% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -1,142,383 | -100.0% | -1.88% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -3,619,015 | -100.0% | -2.05% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -14,406,782 | -100.0% | -2.28% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -2,390,077 | -100.0% | -2.36% | – |
| AMAM | Exit | AMBRX BIOPHARMA INCsponsored ads | $0 | – | -3,488,596 | -100.0% | -2.72% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -1,491,835 | -100.0% | -3.46% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -912,497 | -100.0% | -3.58% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -2,532,972 | -100.0% | -3.75% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -3,681,747 | -100.0% | -3.83% | – |
| Exit | DISC MEDICINE INC | $0 | – | -1,272,279 | -100.0% | -4.06% | – | |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -2,178,737 | -100.0% | -4.40% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -307,314 | -100.0% | -4.71% | – |
| IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -1,384,686 | -100.0% | -4.88% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -1,668,116 | -100.0% | -4.93% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -3,642,307 | -100.0% | -4.96% | – |
| Exit | NUVALENT INC | $0 | – | -1,638,147 | -100.0% | -5.11% | – | |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -7,803,600 | -100.0% | -6.54% | – |
| Exit | ARCELLX INC | $0 | – | -2,953,122 | -100.0% | -7.19% | – | |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -261,443 | -100.0% | -8.72% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -2,025,480 | -100.0% | -9.23% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LEGEND BIOTECH CORP | 8 | Q3 2023 | 10.7% |
| MIRATI THERAPEUTICS INC | 8 | Q3 2023 | 10.9% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 6.8% |
| IMMUNOCORE HLDGS PLC | 8 | Q3 2023 | 5.9% |
| SYNDAX PHARMACEUTICALS INC | 8 | Q3 2023 | 5.8% |
| VOR BIOPHARMA INC | 8 | Q3 2023 | 5.0% |
| INCYTE CORP | 7 | Q3 2023 | 8.6% |
| ARGENX SE | 7 | Q3 2023 | 8.7% |
| UNITED THERAPEUTICS CORP DEL | 7 | Q3 2023 | 7.7% |
| ALPINE IMMUNE SCIENCES INC | 7 | Q3 2023 | 2.1% |
View Paradigm Biocapital Advisors LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-02 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Paradigm Biocapital Advisors LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.